Cargando…
放疗联合免疫治疗非小细胞肺癌：前沿学术问题专家交流共识
Lung cancer is the leading cause of cancer death worldwide as well as in China. For many years, conventional oncologic treatments such as surgery, chemotherapy, and radiotherapy (RT) have dominated the field of non-small cell lung cancer (NSCLC). The recent introduction of immunotherapy in clinical...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309548/ https://www.ncbi.nlm.nih.gov/pubmed/32517461 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.24 |